Navidea Biopharmaceuticals, Inc. (NAVB)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Dec 26, 2024, 3:00 PM EST
NAVB Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Net Income | -1.18 | -15.18 | -11.73 | -10.72 | -10.95 | -16.11 | Upgrade
|
| Depreciation & Amortization | 0.11 | 0.1 | 0.08 | 0.07 | 0.14 | 0.15 | Upgrade
|
| Other Amortization | 0.35 | 0.21 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.07 | 0.07 | 0.1 | 0.01 | 0.06 | - | Upgrade
|
| Stock-Based Compensation | 0.19 | 0.41 | 0.63 | 0.51 | 0.27 | 0.96 | Upgrade
|
| Other Operating Activities | -1.56 | 0.29 | -0.24 | 0.12 | -0 | 5.44 | Upgrade
|
| Change in Accounts Receivable | 0.12 | 0.09 | -0.03 | 0.84 | -0.07 | 12.93 | Upgrade
|
| Change in Inventory | -0.45 | -0.46 | 0.02 | -0.17 | - | - | Upgrade
|
| Change in Accounts Payable | 0.33 | 0.7 | 0.26 | 0.05 | 0.69 | -0.43 | Upgrade
|
| Change in Unearned Revenue | -0.03 | 0.76 | 0.01 | 0.01 | 0 | -0.02 | Upgrade
|
| Change in Other Net Operating Assets | -0.16 | 4.02 | 0.69 | 1.11 | 0.5 | 1.35 | Upgrade
|
| Operating Cash Flow | -9.71 | -8.99 | -10.22 | -8.17 | -9.35 | 4.28 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | -92.76% | Upgrade
|
| Capital Expenditures | -0.02 | -0.06 | -0.03 | -0.14 | - | -0.05 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | - | - | 0 | 0.03 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.18 | -0.33 | -0.3 | -0.28 | -0.06 | - | Upgrade
|
| Investment in Securities | 0.75 | - | - | - | 0.8 | 1 | Upgrade
|
| Investing Cash Flow | 7.98 | -0.39 | -0.33 | -0.41 | 0.77 | 0.95 | Upgrade
|
| Long-Term Debt Issued | - | 2.5 | - | 0.37 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.52 | -0.49 | -0.37 | -0.36 | -0.4 | Upgrade
|
| Net Debt Issued (Repaid) | -0.61 | 1.98 | -0.49 | -0 | -0.36 | -0.4 | Upgrade
|
| Issuance of Common Stock | 0.64 | 0 | 0 | 4.44 | 7.09 | 3 | Upgrade
|
| Repurchase of Common Stock | - | - | -0.02 | - | - | - | Upgrade
|
| Other Financing Activities | -0.14 | -1.01 | -0.07 | -0.21 | -0.57 | -7.15 | Upgrade
|
| Financing Cash Flow | 1 | 7.14 | 12.11 | 10.21 | 6.16 | -4.55 | Upgrade
|
| Net Cash Flow | -0.74 | -2.24 | 1.56 | 1.62 | -2.43 | 0.68 | Upgrade
|
| Free Cash Flow | -9.73 | -9.05 | -10.24 | -8.31 | -9.35 | 4.23 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | -92.84% | Upgrade
|
| Free Cash Flow Margin | -1594888.03% | -13784.28% | -1927.21% | -908.15% | -1422.07% | 361.67% | Upgrade
|
| Free Cash Flow Per Share | -0.18 | -0.29 | -0.35 | -0.35 | -0.65 | 0.50 | Upgrade
|
| Cash Interest Paid | 0.19 | 0.14 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -7.77 | -2.29 | -3.56 | -8.11 | -6.85 | 0.14 | Upgrade
|
| Unlevered Free Cash Flow | -8.12 | -2.29 | -3.55 | -8.1 | -6.84 | 0.24 | Upgrade
|
| Change in Net Working Capital | 1.83 | -4.75 | -3.6 | 1.58 | 0.35 | -5.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.